-
1 Comment
Shofu Inc is currently in a long term uptrend where the price is trading 9.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Shofu Inc's total revenue rose by 5.7% to $7B since the same quarter in the previous year.
Its net income has increased by 44.5% to $578M since the same quarter in the previous year.
Based on the above factors, Shofu Inc gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Instruments & Supplies |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3363600002 |
| Dividend Yield | 2.0% |
|---|---|
| PE Ratio | 17.37 |
| Market Cap | 77B |
| Beta | 0.22 |
| Target Price | 3333.3333 |
Shofu Inc. manufactures and sells dental materials and equipment worldwide. Its products include abrasives, diamonds and carbides, cements, preventives, restoratives, ceramics, CAD/CAM, dental cameras, tickers, instruments, polishings, prosthetics, rotary instruments, adhesives, porcelain systems, indirect composite, dental waxes, articulators, acrylic materials and artificial teeth, C&B composites, filling and fixing, prophylaxis, and prefabricated teeth. The company offers nail care products and equipment. It also imports and exports its products. The company was formerly known as Shofu Dental Mfg. Co., Ltd. and changed its name to Shofu Inc. in 1983. Shofu Inc. was incorporated in 1922 and is based in Kyoto, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7979.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
